NCT04771130: A Study of BGB-11417 in Participants With Myeloid Malignancies
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 260 planned
- Started
- 24 May 2021
- Primary completion
- 31 Aug 2028
- Arms
- Part 3: AML and MDS Cohort
- Results
- None posted
- 25 Feb 2021: Trial registered
- 24 May 2021: Trial started